
Today on Pharmaceutical Processing
Siemens Healthineers links with Novo to advance liver fibrosis blood test
Siemens Healthineers has teamed up with the recently rebranded drugmaker Novo on a project to advance its blood test for hidden liver disease, in a bid to deliver earlier diagnoses and access to treatment. Aimed at the category of metabolic dysfunction-associated steatotic liver disease, or MASLD — and its progressive stage, metabolic dysfunction-associated steatohepatitis, commonly…Artis BioSolutions announces new center of excellence in Spain
Artis BioSolutions announced the launch of its Genetics Medicines Center of Excellence in Bilbao, Spain, where it already has a facility specializing in synthetic DNA manufacturing. The company, which also has facilities in Boston and San Diego, supports genetic medicine developers with manufacturing processes. It was cofounded by Harvard University, MIT and Boston research hospitals as Landmark Bio.…Sponsored Content See More >
Regulatory See More >

Fujifilm Biotechnologies selected for FDA PreCheck Pilot Program
A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…
Learn how to rapidly develop smart and sustainable engineering and production processes See More >

Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >

ISO 9001, 14001 and 45001 revisions: What changes and when to start
ISO 9001, ISO 14001 and ISO 45001 are all being revised, which leaves quality (QMS), environmental (EMS) and occupational health and safety (OH&S) managers, along with top management, with required work ahead to meet the new requirements. Because the revisions put more weight on climate change, resilience, ethics and people-related issues, they are more than…
Supply Chain See More >

Bristol Myers Squibb to build new plant in Houston
Bristol Myers Squibb (NYSE: BMY) announced it has selected Houston as the site for a new 600,000-square-foot multi-modal manufacturing campus, representing an approximately $2.3 billion investment. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs, the company said. The campus’ multi-modal capabilities will allow BMS to manufacture multiple types of medicines – such as…
Recalls See More >

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…







































